TNXP

Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals Holding Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:TNXP

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/12/23	22:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/23	22:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces PDUFA Goal Date of August 15, 2025, for FDA Decision on U.S. Marketing Approval for TNX-102 SL for Fibromyalgia	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/21	06:17	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/21	06:16	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/17	23:25	AllPennyStocks.com	This Micro Cap Is Getting Bid Up Prior To Opening Bell	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/17	22:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/17	22:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces FDA Acceptance of the New Drug Application (NDA) for TNX-102 SL for Fibromyalgia	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/07	06:13	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/03	21:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/12/03	21:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Expansion of Leadership Team with Two Strategic Hires	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/26	21:00	GlobeNewswire Inc.	Tonix Pharmaceuticals to Participate in the NobleCon20 Investor Conference	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/19	06:05	GlobeNewswire Inc.	Tonix Pharmaceuticals to Present at the Winter 2024 Investor Summit Virtual	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/18	21:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/15	06:42	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/15	06:40	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/14	06:05	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Poster Presentation at the American College of Rheumatology (ACR) Convergence 2024 Annual Meeting	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/13	23:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/13	23:05	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Peer-Reviewed Publication in mSphere Journal Highlighting the Tolerability of Company’s Single-Dose Mpox and Smallpox Vaccine Candidate TNX-801, in Immune-Compromised Animals	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/13	07:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/12	22:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/12	22:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Highlights	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/09	07:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/04	21:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/04	21:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/01	20:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/11/01	20:00	GlobeNewswire Inc.	Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress-Europe 2024	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/10/31	05:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/10/29	21:00	GlobeNewswire Inc.	Tonix Pharmaceuticals to Present at BIO-Europe® 2024	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/10/29	06:16	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation
2024/10/25	21:00	GlobeNewswire Inc.	Tonix Pharmaceuticals to Present at the 2024 ThinkEquity Conference	NASDAQ:TNXP	Tonix Pharmaceuticals Holding Corporation